[EN] DIARYL ETHER ß2 ADRENERGIC RECEPTOR AGONISTS<br/>[FR] AGONISTES DES RÉCEPTEURS ß2-ADRÉNERGIQUES DÉRIVÉS D'ÉTHERS DE DIARYLE
申请人:THERAVANCE INC
公开号:WO2006014704A1
公开(公告)日:2006-02-09
The invention provides novel Diaryl Ether derivatives as beta2 adrenergic receptor agonists. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with beta2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.